VandenBerg Amy 4
4 · OBALON THERAPEUTICS INC · Filed Jan 28, 2020
Insider Transaction Report
Form 4
VandenBerg Amy
Chief Clinical & Reg Officer
Transactions
- Award
Restricted Stock Units
[F1]2020-01-24+88,225→ 88,225 total→ Common Stock (88,225 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.
Signature
/s/ Nooshin Hussainy as attorney-in-fact for Amy VandenBerg|2020-01-28